Emerald Advisers’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-490
Closed -$9K 300
2021
Q4
$9K Buy
+490
New +$9.51K ﹤0.01% 275
2021
Q3
Sell
-490
Closed -$16K 300
2021
Q2
$16K Buy
+490
New +$18.5K ﹤0.01% 280
2021
Q1
Sell
-490
Closed -$21K 308
2020
Q4
$21K Hold
490
﹤0.01% 278
2020
Q3
$14K Hold
490
﹤0.01% 301
2020
Q2
$18K Sell
490
-268,533
-100% -$7.56M ﹤0.01% 268
2020
Q1
$4.88M Buy
+269,023
New +$5.9M 0.28% 100

Other funds holding ONEM

Emerald Advisers's ONEM Position: Q1 2022 in Review

Emerald Advisers sold out of 1Life Healthcare (ONEM) in Q1 2022, closing a stake of 490 shares — an estimated $9K sold.

Emerald Advisers first reported a position in ONEM in Q1 2020 and held it in 6 quarters. The position peaked at $4.88M in Q1 2020. 189 funds tracked by Wall St. Rank hold ONEM as of Q1 2022.

  • Emerald Advisers reported no remaining 1Life Healthcare position as of Q1 2022 after selling out during the quarter.
  • Emerald Advisers sold 490 1Life Healthcare shares in Q1 2022, an estimated $9K.
  • Emerald Advisers first reported a position in 1Life Healthcare in Q1 2020 and held it in 6 quarters.
  • Emerald Advisers's 1Life Healthcare position peaked at $4.88M in Q1 2020.
  • 189 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2022.

Based on Emerald Advisers's 13F filing for Q1 2022, filed 29 Apr 2022.